Samlyn Capital’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-953,711
Closed -$14.2M 135
2019
Q2
$14.2M Buy
953,711
+582,871
+157% +$8.67M 0.3% 66
2019
Q1
$9.2M Sell
370,840
-634,397
-63% -$15.7M 0.22% 73
2018
Q4
$18.1M Buy
+1,005,237
New +$18.1M 0.43% 60
2018
Q2
Sell
-308,119
Closed -$16.3M 149
2018
Q1
$16.3M Sell
308,119
-376,417
-55% -$19.9M 0.36% 74
2017
Q4
$46.5M Buy
684,536
+162,191
+31% +$11M 1.07% 36
2017
Q3
$43M Sell
522,345
-45,355
-8% -$3.74M 1.09% 31
2017
Q2
$53.2M Buy
567,700
+322,800
+132% +$30.2M 1.3% 29
2017
Q1
$15.6M Sell
244,900
-658,900
-73% -$42M 0.36% 69
2016
Q4
$40.1M Buy
903,800
+373,889
+71% +$16.6M 0.91% 47
2016
Q3
$19.1M Sell
529,911
-148,499
-22% -$5.35M 0.45% 74
2016
Q2
$9.31M Buy
+678,410
New +$9.31M 0.22% 77